COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 959: Articles 9581-9590  | Next

City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants
Brunner, F. S., Brown, M. R., Bassano, I., Denise, H., Khalifa, M. S., Wade, M., Kevill, J. L., Jones, D. L., Farkas, K., Jeffries, A. R., The COVID-19 Genomics UK (COG-UK) Consortium, , Cairns, E., Wierzbicki, C., Paterson, S.
10.1101/2022.02.16.22269810 — Posted: 2022-02-16
SARS-CoV-2 Omicron BA.2 Variant Evades Neutralization by Therapeutic Monoclonal Antibodies
Zhou, H., Tada, T., Dcosta, B. M., Landau, N. R.
10.1101/2022.02.15.480166 — Posted: 2022-02-16 Discussion: Onsite
SARS-CoV-2 variants show a gradual declining pathogenicity and pro-inflammatory cytokine stimulation and an increasing antigenic and anti-inflammatory cytokine induction
Barh, D., Tiwari, S., Gomes, L. G. R., Pinto, C. H. R., Andrade, B., Ahmad, S., Aljabali, A. A. A., Alzahrani, K. J., Banjer, H. J., Hassan, S. S., Tambuwala, M., Redwan, E. M., Raza, K., Azevedo, V., Lundstrom, K., Uversky, V. N.
10.1101/2022.02.15.480592 — Posted: 2022-02-16
Non-productive exposure of PBMCs to SARS-CoV-2 induces cell-intrinsic innate immunity responses
Kazmierski, J., Friedmann, K., Postmus, D., Fischer, C., Jansen, J., Richter, A., Bosquillon de Jarcy, L., Schüler, C., Sohn, M., Sauer, S., Drosten, C., Saliba, A.-E., Sander, L., Niemeyer, D., Goffinet, C.
10.1101/2022.02.15.480527 — Posted: 2022-02-16
Distinguishing Admissions Specifically for COVID-19 from Incidental SARS-CoV-2 Admissions: A National EHR Research Consortium Study
Klann, J. G., Strasser, Z. H., Hutch, M. R., Kennedy, C. J., Marwaha, J. S., Morris, M., Samayamuthu, M. J., Pfaff, A. C., Estiri, H., South, A. M., Weber, G. M., Yuan, W., Avillach, P., Wagholikar, K. B., Luo, Y., The Consortium for Clinical Characterization of COVID-19 by EHR (4CE), , Omenn, G. S., Visweswaran, S., Holmes, J. H., Xia, Z., Brat, G. A., Murphy, S. N.
10.1101/2022.02.10.22270728 — Posted: 2022-02-15
CT-Guided Direct Current Cardioversion for Atrial Arrhythmias During the COVID-19 Pandemic
Veillet-Chowdhury, M., Sharaf Dabbagh, G., Benton, S. M., Hill, A. M., Lee, J. H., Singleton, M. J., Fazio, G. P., Harvey, J. E., Samady, H., Singh, D., Khanji, M. Y., Nazarian, S., Pugliese, F., Obeng-Gyimah, E., Schuler, B. T., Chahal, C. A. A.
10.1101/2022.02.13.22270911 — Posted: 2022-02-15
Bayesian Space-time SIR modeling of Covid-19 in two US states during the 2020-2021 pandemic.
Lawson, A. B., Kim, J.
10.1101/2022.02.14.22270941 — Posted: 2022-02-15
Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine roll-out: a retrospective, population-based cohort study
Bosworth, M. L., Ahmed, T., Larsen, T., Lorenzi, L., Morgan, J., Ali, R., Goldblatt, P., Islam, N., Khunti, K., Raleigh, V., Ayoubkhani, D., Bannister, N., Glickman, M., Nafilyan, V.
10.1101/2022.02.14.22270940 — Posted: 2022-02-15
Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)
Jolliffe, D. A., Faustini, S. E., Holt, H., Perdek, N., Maltby, S., Talaei, M., Greenig, M., Vivaldi, G., Tydeman, F., Symons, J., Davies, G. A., Lyons, R., Kee, F., Sheikh, A., Shaheen, S. O., Richter, A., Martineau, A. R.
10.1101/2022.02.14.22270930 — Posted: 2022-02-15
Fourth Dose COVID mRNA Vaccines' Immunogenicity & Efficacy Against Omicron VOC
Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., Meltzer, L., Asraf, K., Cohen, C., Fluss, R., Biber, A., Nemet, I., Kliker, L., Joseph, G., Doolman, R., Mendelson, E., Freedman, L. S., Harats, D., Kreiss, Y., Lustig, Y.
10.1101/2022.02.15.22270948 — Posted: 2022-02-15 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).